- £25.35bn
- £34.32bn
- $9.67bn
- 76
- 28
- 73
- 63
2019 April 30th | 2020 April 30th | R2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,867 | 6,395 | 6,639 | 7,962 | 9,667 |
Cost of Revenue | |||||
Gross Profit | 4,452 | 4,845 | 4,971 | 5,784 | 7,248 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,285 | 4,867 | 5,141 | 6,062 | 7,145 |
Operating Profit | 1,581 | 1,528 | 1,498 | 1,901 | 2,522 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,381 | 1,244 | 1,235 | 1,668 | 2,156 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,039 | 936 | 920 | 1,251 | 1,618 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,039 | 936 | 920 | 1,251 | 1,618 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,039 | 936 | 920 | 1,251 | 1,618 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.62 | 2.8 | 2.9 | 3.6 | 4.86 |
Dividends per Share |